Citi analyst Joanne Wuensch raised the firm’s price target on Stryker to $290 from $282 and keeps a Buy rating on the shares following the better than expected Q4 results. The analyst anticipates the shares will respond positively to the release reiterates the stock as a "Citi Top Pick."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SYK: